Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis B virus therapeutic vaccine
- Development stage
- Preclinical
- Lead developer
- Auro Vaccines
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The hepatitis B virus therapeutic vaccine is an **Auro Vaccines** preclinical heterologous prime-boost immunotherapy for chronic hepatitis B. It uses the PBS Vax platform: a GeneVax DNA-plasmid prime encoding hepatitis B virus antigens, co-administered with the GeneVax IL-12 plasmid molecular adjuvant and delivered by electroporation, followed by a VesiculoVax vesiculovirus-vectored boost. The program is designed to generate durable antiviral T-cell responses against cells infected with hepatitis B virus across all eight HBV genotypes, with the intended use as an adjunct to antiviral drug therapy to achieve functional control or cure of chronic infection. Preclinical small-animal development was completed; further development is on hold and the program is available for out-licensing or co-development.
- Other names
- 8-genotype HBV vaccineHBV Therapeutic Vaccine
Beyond the preview
Go deeper on hepatitis B virus therapeutic vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis B virus therapeutic vaccine.